[RHBBANK] YoY Quarter Result on 31-Dec-2015 [#4]

Stock
[RHBBANK] RHB BANK BERHAD
Announcement Date
26-Feb-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Dec-2015 [#4]
Profit Trend
QoQ- 58.5%
YoY- -25.26%
Quarter Report
Latest QR
Upcoming QR
RHBBANK's Result
RHBBANK's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 3,309,713 2,702,271 2,557,553 2,818,305 2,835,305 2,512,512 2,227,719 6.81%
PBT 775,096 601,879 344,411 518,076 643,586 683,055 560,320 5.55%
Tax -207,541 -139,775 -87,693 -152,947 -144,616 -187,306 -149,291 5.64%
NP 567,555 462,104 256,718 365,129 498,970 495,749 411,029 5.52%
-
NP to SH 565,425 460,077 261,243 363,374 486,191 504,517 407,864 5.59%
-
Tax Rate 26.78% 23.22% 25.46% 29.52% 22.47% 27.42% 26.64% -
Total Cost 2,742,158 2,240,167 2,300,835 2,453,176 2,336,335 2,016,763 1,816,690 7.09%
-
Net Worth 23,338,462 23,137,959 21,734,444 6,774,000 18,804,530 16,656,667 14,454,127 8.30%
Dividend
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Div 521,305 401,004 280,703 433,801 154,346 261,131 383,773 5.23%
Div Payout % 92.20% 87.16% 107.45% 119.38% 31.75% 51.76% 94.09% -
Equity
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Net Worth 23,338,462 23,137,959 21,734,444 6,774,000 18,804,530 16,656,667 14,454,127 8.30%
NOSH 4,010,045 4,010,045 4,010,045 2,656,470 2,572,439 2,535,261 2,385,169 9.04%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 17.15% 17.10% 10.04% 12.96% 17.60% 19.73% 18.45% -
ROE 2.42% 1.99% 1.20% 5.36% 2.59% 3.03% 2.82% -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 82.54 67.39 63.78 106.09 110.22 99.10 93.40 -2.03%
EPS 14.10 11.50 6.50 5.30 18.90 19.90 17.10 -3.16%
DPS 13.00 10.00 7.00 16.33 6.00 10.30 16.09 -3.49%
NAPS 5.82 5.77 5.42 2.55 7.31 6.57 6.06 -0.67%
Adjusted Per Share Value based on latest NOSH - 2,656,470
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
RPS 77.22 63.04 59.67 65.75 66.15 58.62 51.97 6.81%
EPS 13.19 10.73 6.09 8.48 11.34 11.77 9.52 5.58%
DPS 12.16 9.36 6.55 10.12 3.60 6.09 8.95 5.23%
NAPS 5.4448 5.3981 5.0706 1.5804 4.3871 3.886 3.3721 8.30%
Price Multiplier on Financial Quarter End Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 -
Price 5.29 5.00 4.71 5.67 7.62 7.90 7.69 -
P/RPS 6.41 7.42 7.38 5.34 6.91 7.97 8.23 -4.07%
P/EPS 37.52 43.58 72.30 41.45 40.32 39.70 44.97 -2.97%
EY 2.67 2.29 1.38 2.41 2.48 2.52 2.22 3.12%
DY 2.46 2.00 1.49 2.88 0.79 1.30 2.09 2.75%
P/NAPS 0.91 0.87 0.87 2.22 1.04 1.20 1.27 -5.40%
Price Multiplier on Announcement Date
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Date 27/02/19 27/02/18 24/02/17 26/02/16 27/02/15 24/02/14 26/02/13 -
Price 5.59 5.47 4.93 5.35 7.96 7.77 7.76 -
P/RPS 6.77 8.12 7.73 5.04 7.22 7.84 8.31 -3.35%
P/EPS 39.64 47.68 75.67 39.11 42.12 39.05 45.38 -2.22%
EY 2.52 2.10 1.32 2.56 2.37 2.56 2.20 2.28%
DY 2.33 1.83 1.42 3.05 0.75 1.33 2.07 1.99%
P/NAPS 0.96 0.95 0.91 2.10 1.09 1.18 1.28 -4.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment